465 Studies Now Enrolling
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY,EFFICACY, AND TREATMENT REGIMEN OF ST266 IN SUBJECTS WITH MODERATE TO SEVEREPERIODONTITIS
Gum Disease Study
| Sponsor: | Noveome |
| Enrolling: | Male and Female Patients |
| Study Length: | 9 Months |
| Clinic Visits: | 9 |
| IRB Number: | AAAQ7851 |
| U.S. Govt. ID: | NCT02761993 |
| Contact: | Romanita Celenti: 212-305-9308 / rsc1@columbia.edu |
Additional Study Information:
This study is for healthy subjects with gum (periodontal) disease. The purpose of this study is to study a new investigational topical medication applied to the gums that may improve the signs and symptoms of gym disease. The study requires you to come visit our clinic for approximately 9 evaluation visits and up to 29 treatments visits over a 9 month study period.
This study is closed
